Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis
- 1 April 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (4) , 519-521
- https://doi.org/10.1128/aac.33.4.519
Abstract
The efficacy of fleroxacin versus that of vancomycin was assessed by using the rabbit model of methicillin-resistant Staphylococcus aureus endocarditis. Animals were treated with fleroxacin (30 mg/kg of body weight every 8 h) or vancomycin (17.5 mg/kg every 6 h) for 4 days. These antimicrobial agents were equally effective in clearing bacteremia, reducing bacterial counts in vegetations and tissues, and curing endocarditis. However, resistance to fleroxacin at fivefold the MIC arose in the test strain of S. aureus in 8% of animals that received the drug. We conclude that fleroxacin is as efficacious as vancomycin in this model of a serious systemic S. aureus infection, but modest resistance to fleroxacin may develop during therapy.This publication has 12 references indexed in Scilit:
- Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humansAntimicrobial Agents and Chemotherapy, 1987
- The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditisJournal of Antimicrobial Chemotherapy, 1987
- Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbitsAntimicrobial Agents and Chemotherapy, 1987
- Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditisAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneAntimicrobial Agents and Chemotherapy, 1986
- Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditisAntimicrobial Agents and Chemotherapy, 1986
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1985
- Automated Fluorescence Polarization Immunoassay for Monitoring VancomycinTherapeutic Drug Monitoring, 1983
- Serum Dilution Test for Bactericidal Activity. I. Selection of a Physiologic DiluentThe Journal of Infectious Diseases, 1977